Millennium News Release
Posted in Multiple Myeloma on Dec 26th, 2011
“Elderly patients with multiple myeloma strive for upfront therapy that will extend their lives,” said Karen Ferrante, M.D., Chief Medical Officer, Millennium. “Today’s VELCADE data confirmed the sustained clinical benefits, including overall survival and complete response that VELCADE provided in patients with previously untreated MM.” Peter, a member of the MM ListServ (moderated by Beth […]
